KFG
EW icon

Kingdom Financial Group’s Edwards Lifesciences EW Stock Holding History

Kingdom Financial Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.8K Hold
60
– – ﹤0.01% 567
2025
Q4 		$5.12K Buy
+60
New +$4.92K ﹤0.01% 488

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Kingdom Financial Group's EW Position: Q1 2026 in Review

Kingdom Financial Group held its Edwards Lifesciences (EW) position steady in Q1 2026 at 60 shares worth $4.8K. The position accounts for ﹤0.01% of the portfolio, ranked #567.

Kingdom Financial Group first reported a position in EW in Q4 2025 and has held it in 2 quarters since. The position peaked at $5.12K in Q4 2025. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Kingdom Financial Group held 60 shares of Edwards Lifesciences worth $4.8K as of Q1 2026.
  • Kingdom Financial Group left its Edwards Lifesciences share count unchanged in Q1 2026.
  • Edwards Lifesciences made up ﹤0.01% of Kingdom Financial Group's portfolio in Q1 2026, its #567 holding.
  • Kingdom Financial Group first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 2 quarters since.
  • Kingdom Financial Group's Edwards Lifesciences position peaked at $5.12K in Q4 2025.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Kingdom Financial Group's 13F filing for Q1 2026, filed 13 May 2026.